Update – Weight loss drug – Mounjaro

Message from the Staffordshire & Stoke on Trent Integrated Care Board – Weight Management Services update, Mounjaro

***

We are receiving a significant number of enquiries about the availability of the Mounjaro weight-loss drug which has been approved by NHS England for eligible patients.

NHS England has set the criteria for eligibility for the drug; this is a national policy which all NHS prescribers, such as GPs and pharmacists, are required to abide by.

The criteria for weight management cannot be changed by prescribers.

Although NHS England has approved the drug, all GPs are waiting for information about how the drug will be provided to eligible patients, when, and for how long.

We are also awaiting guidance about how the drug should be used by patients along with other services to support weight management, such as diet and exercise.

Current guidance is that anyone with a BMI of 40 or higher, and with four or more of the qualifying comorbidities (hypertension, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease and type 2 diabetes) will be eligible for assessment to identify their suitability for Mounjaro.

Anyone not meeting these criteria will not be eligible for assessment in the first year of the drug being available.